News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
18 Apr 24
Movers
University Of Minnesota Masonic Cancer Center Intends To Expand Cirtrus Pharmaceuticals' Ongoing Investigator-Initiated Phase 1 Trial Of LYMPHIR In Combination With FDA-Approved CAR-T Products For B-cell Lymphomas
11 Apr 24
Biotech, News, General
Citius Pharmaceuticals Announces FDA Acceptance Of BLA Resubmission of LYMPHIR For Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma
18 Mar 24
Biotech, News, FDA, General
Citius Pharma Q1 EPS $(0.06) Down From $(0.02) YoY
14 Feb 24
Earnings, News
HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target
14 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
18 Apr 24
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
11 Apr 24
Small Cap, Press Releases
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
4 Apr 24
Press Releases
Thinking about buying stock in Velo3D, Nova Lifestyle, indie Semiconductor, Citius Pharmaceuticals, or Transcode Therapeutics?
22 Mar 24
Small Cap, Opinion, Press Releases
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
7 Mar 24
Press Releases
Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences
23 Feb 24
Small Cap, Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update
14 Feb 24
Earnings, Small Cap, Press Releases
Citius Pharmaceuticals Resubmits the Biologics License Application of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
14 Feb 24
Small Cap, Press Releases